953
Views
10
CrossRef citations to date
0
Altmetric
Original Articles

Percutaneous microwave ablation (MWA) increased the serum levels of VEGF and MMP-9 in Stage I non-small cell lung cancer (NSCLC)

, , , , , , , , , & show all
Pages 435-439 | Received 11 Dec 2016, Accepted 14 Jan 2017, Published online: 02 Feb 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Zhigang Wei, Qingyu Li, Xin Ye, Xia Yang, Guanghui Huang, Wenhong Li, Jiao Wang & Xiaoying Han. (2021) Microwave ablation or plus monochemotherapy in elderly advanced non-small-cell lung cancer patients. Minimally Invasive Therapy & Allied Technologies 30:2, pages 106-114.
Read now
Yang Ni, Xia Yang, Jian Cui, Zhichao Li, Pingping Yang, Jiaju Xu, Guanglian Shan & Xin Ye. (2020) Combined microwave ablation and antiangiogenic therapy to increase local efficacy. Minimally Invasive Therapy & Allied Technologies 29:2, pages 107-113.
Read now

Articles from other publishers (8)

Jing Wang, Song-ping Cui, Qing Zhao, Ya Gao, Ying Ji, Yi Liu, Jin-bai Miao, Yi-li Fu & Bin Hu. (2024) Preoperative systemic immune-inflammation index-based nomogram for lung carcinoma following microwave ablation -a real world single center study. Frontiers in Oncology 14.
Crossref
Xinhang Hu, Qikang Hu, Yu He, Xuyang Yi, Zeyu Wu, Huali Hu, Yifan Ouyang, Fenglei Yu & Muyun Peng. (2024) Efficacy and safety of microwave ablation and its synergistic potential in the treatment of early-stage non-small cell lung cancer. Clinical Imaging 107, pages 110070.
Crossref
Ziwang Ren, Guiling Feng, Bing Li, Chuan Zhang & Yong Du. (2024) Dynamic contrast-enhanced magnetic resonance imaging assessment of residual tumor angiogenesis after insufficient microwave ablation and donafenib adjuvant therapy. Scientific Reports 14:1.
Crossref
Bing Dong, Xiaowei Liu, Su Wang, Xiujun Chen, Kun Zhang & Yan Zhang. (2023) microRNA-125a-5p as a Tumor Suppressor in Non-Small Cell Lung Cancer (NSCLC): Inhibition of Proliferation and Induction of Apoptosis via P13K/AKT/MMP Signaling Pathway. Science of Advanced Materials 15:4, pages 544-550.
Crossref
Li Yin, Xing-yu Li, Lin-lin Zhu, Gui-lai Chen, Zhuo Xiang, Qing-qing Wang, Jing-wang Bi & Qiang Wang. (2022) Clinical application status and prospect of the combined anti-tumor strategy of ablation and immunotherapy. Frontiers in Immunology 13.
Crossref
Lile Wang, Ruicheng Hu & Aiguo Dai. (2022) Curcumin Increased the Sensitivity of Non-Small-Cell Lung Cancer to Cisplatin through the Endoplasmic Reticulum Stress Pathway. Evidence-Based Complementary and Alternative Medicine 2022, pages 1-15.
Crossref
Pierpaolo Biondetti, Lorenzo Saggiante, Anna Maria Ierardi, Massimo Iavarone, Angelo Sangiovanni, Filippo Pesapane, Enrico Maria Fumarola, Pietro Lampertico & Gianpaolo Carrafiello. (2021) Interventional Radiology Image-Guided Locoregional Therapies (LRTs) and Immunotherapy for the Treatment of HCC. Cancers 13:22, pages 5797.
Crossref
Zhigang Wei, Xia Yang, Xin Ye, Qingliang Feng, Yanjun Xu, Licheng Zhang, Wenqiao Sun, Yuting Dong, Qi Meng, Tao Li, Chuntang Wang, Guangxu Li, Kaixian Zhang, Peishun Li, Jingwang Bi, Guoliang Xue, Yahong Sun, Lijun Sheng, Bin Liu, Guohua Yu, Haipeng Ren, Junye Wang, Lijun Sun, Shaoshui Chen, Dianzhong Geng, Benhua Zhang, Xin Xu, Liangming Zhang, Dengjun Sun, Xinglu Xu, Cunqi Diao, Guanghui Huang, Wenhong Li, Xiaoying Han, Jiao Wang, Min Meng, Yang Ni, Aimin Zheng, Weijun Fan, Yuliang Li, Fan Li, Hua Fan, Zhigeng Zou, Qingyu Li & Hui Tian. (2020) Microwave ablation plus chemotherapy versus chemotherapy in advanced non-small cell lung cancer: a multicenter, randomized, controlled, phase III clinical trial. European Radiology 30:5, pages 2692-2702.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.